Genomic characterization and molecular predictive biomarkers for chemotherapy in a real-world population with metastatic triple-negative breast cancer

被引：0
|
作者：
Olsson, Erik
Lindman, Henrik
Digkas, Evangelos
Thurfjell, Viktoria
Ali, Haidar Mir
Kruger, Ute
Wennstig, Anna-Karin
Sundqvist, Marie
Valachis, Antonis
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-15-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-15-05
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
    Olsson, Erik
    Lindman, Henrik
    Digkas, Evangelos
    Thurfjell, Viktoria
    Ali, Haidar Mir
    Kruger, Ute
    Wennstig, Anna-Karin
    Sundqvist, Marie
    Valachis, Antonios
    BREAST, 2025, 79
  • [2] Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer
    Skinner, Karen E.
    Haiderali, Amin
    Huang, Min
    Schwartzberg, Lee S.
    FUTURE ONCOLOGY, 2021, 17 (08) : 931 - 942
  • [3] Effectiveness and safety of neoadjuvant therapy in triple-negative breast cancer in a real-world population
    Garcia, Cristina Galindo
    Acedo, Rocio Diaz
    Criado, Silvia Artacho
    Artacho, Maria Rodriguez de la Borbolla
    FARMACIA HOSPITALARIA, 2024, 48 (06) : 278 - 285
  • [4] Molecular biomarkers as predictive factors of pCR for early triple-negative breast cancer
    Ghanem, Ismael
    Castaneda, Carlos
    Perez-Campos, Ana
    Toldos, Oscar
    Sancho Perez, Blanca
    Manso, Luis
    Luis Rodriguez-Peralto, Jose
    Calderon, Monica
    Corles-Funes, Herman
    Lora, David
    Garcia-Martin, Rosa
    Ciruelos, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Utilisation and Outcomes of Eribulin in Triple-Negative Metastatic Breast Cancer (TN MBC): Real-World Findings
    Kish, Jonathan K.
    Mougalian, Sarah S.
    Copher, Ronda
    McAllister, Lindsay
    Wang, Zhixiao
    Janevski, Mile
    Broscious, Mary
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 123 - 123
  • [6] Efficacy and safety of adding carboplatin in neoadjuvant chemotherapy for triple-negative breast cancer - real-world data
    Leung, K. H.
    Kwok, C. C. H.
    BREAST, 2025, 80
  • [7] Efficacy and safety of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer: Real-world data
    Rached, L. W.
    Spotti, M. P.
    Baldini, C.
    Laparra, A.
    Remote, C. A. Dutertre
    Sakkal, M.
    Perret, A.
    Viansone, A. A.
    Zeghondy, J. Z.
    Rassy, E.
    Bousrih, C.
    Abdayem, P.
    Abboud, R. M. Khoury
    El Masri, H. K.
    Grinda, T.
    Terencio, S. Moragon
    Verret, B.
    Champiat, S.
    Pistilli, B.
    Ribeiro, J. T. M. L.
    ANNALS OF ONCOLOGY, 2023, 34 : S288 - S288
  • [8] Real-world data on triple-negative breast cancer in Latin America and the Caribbean
    Tiscoski, Katsuki Arima
    Giacomazzi, Juliana
    Rocha, Matheus Soares
    Goessling, Gustavo
    Werutsky, Gustavo
    ECANCERMEDICALSCIENCE, 2023, 17
  • [9] Genomic instability and telomere characteristics as predictive biomarkers of therapeutic response in triple-negative breast cancer
    Gay-Bellile, Mathilde
    Radosevic-Robin, Nina
    Eymard-Pierre, Eleonore
    Kwiatkowski, Fabrice
    Dauplat, Marie-Melanie
    Privat, Maud
    Abrial, Catherine
    Combes, Patricia
    Soler, Gwendoline
    Bignon, Yves-Jean
    Nabholtz, Jean-Marc
    Vago, Philippe
    Penault-Llorca, Frederique
    Tchirkov, Andrei
    CANCER RESEARCH, 2014, 74 (19)
  • [10] A real-world study on the clinical value of apatinib-based regimens in metastatic triple-negative breast cancer
    Wei, H. W.
    Qi, C.
    Kun, S.
    Xi, W.
    Jian, H.
    Jian, L.
    Li, W.
    Fan, W.
    Chen, X.
    Ni, L.
    Yi, H.
    Lan, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S360 - S360
12345